Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection Reactivation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00465205
What this trial is testing

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

Who this might be right for
HIV InfectionsHerpes SimplexSexually Transmitted Diseases
University of Washington 20
Post-approval studies (Phase 4)Study completedNCT00527618
What this trial is testing

Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV

Who this might be right for
Genital HerpesHIV Infection
University of Washington 28
Not applicableEnded earlyNCT02873325
What this trial is testing

Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT

Who this might be right for
Infectious Complications Following HSCT
Cell Medica Ltd 1
Post-approval studies (Phase 4)UnknownNCT05914701
What this trial is testing

Secondary Prophylaxis of CMV Infection Using Letermovir After HID-HSCT

Who this might be right for
To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
Institute of Hematology & Blood Diseases Hospital, China 31
Early research (Phase 1)Study completedNCT04153279
What this trial is testing

CMV-TCR-T Cells for CM Virus Infection After HSCT

Who this might be right for
CMV Infection or Reactivation After Allogenic HSCT
Hebei Yanda Ludaopei Hospital 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07138989
What this trial is testing

EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 10
Not applicableStudy completedNCT00173433
What this trial is testing

Exogenous Reinfection of Tuberculosis in Taiwan

Who this might be right for
Tuberculosis
National Taiwan University Hospital 150
Not applicableStudy completedNCT01311232
What this trial is testing

Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab

Who this might be right for
Patients With Diffuse Large B-cell Lymphoma or Follicular LymphomaPatients Treated With Rituximab-CHOP or Rituximab-CVP
Samsung Medical Center 600
Testing effectiveness (Phase 2)Looking for participantsNCT02048332
What this trial is testing

Donor-Derived Viral Specific T-cells (VSTs)

Who this might be right for
Allogeneic Stem Cell TransplantViral InfectionViral Reactivation
Children's Hospital Medical Center, Cincinnati 1,000
Not applicableStudy completedNCT00876148
What this trial is testing

Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting

Who this might be right for
Hepatitis B VirusAllograftHematological Malignancies
Azienda Ospedaliera San Giovanni Battista
Not applicableNot Yet RecruitingNCT06936683
What this trial is testing

Herpes Simplex Virus Type 1 Infection/Reactivation of Patients With Severe Pneumonia（the HSV-SP Study）

Who this might be right for
Severe Pneumonia
Second Affiliated Hospital of Guangzhou Medical University 323
Testing effectiveness (Phase 2)UnknownNCT06282783
What this trial is testing

Studying Topiramate for Re-Activating the HIV-1 Reservoir

Who this might be right for
HIV-1-infectionHivHIV Infections+1 more
Erasmus Medical Center 12
Testing effectiveness (Phase 2)UnknownNCT01633476
What this trial is testing

CMV Modulation of the Immune System in ANCA-associated Vasculitis

Who this might be right for
ANCA Associated VasculitisCMV Infection
Professor Lorraine Harper 38
Not applicableLooking for participantsNCT07693881
What this trial is testing

Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
EBV Infection After Allogenic HSCT
Nanfang Hospital, Southern Medical University 106
Not applicableUnknownNCT06421259
What this trial is testing

Descriptive Analysis of Changes in Hepatitis B Markers in People Living With HIV on Injectable Therapy.

Who this might be right for
Hiv InfectionHepatitis B
Centre Hospitalier Universitaire de Nice 15
Early research (Phase 1)Study completedNCT00078533
What this trial is testing

Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant

Who this might be right for
Cytomegalovirus Infections
Baylor College of Medicine 26
Not applicableNot Yet RecruitingNCT06426758
What this trial is testing

Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation

Who this might be right for
Graves DiseaseGraves' Disease in RemissionEpstein-Barr Virus
Xiao-Ming Mao 300
Not applicableStudy completedNCT03618862
What this trial is testing

Study of the Effects of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent Provirus

Who this might be right for
Hiv
Hospices Civils de Lyon 38
Not applicableStudy completedNCT03528941
What this trial is testing

The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib

Who this might be right for
Chronic Lymphocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 109
Post-approval studies (Phase 4)UnknownNCT05914675
What this trial is testing

Letermovir for Primary Prophylaxis of Cytomegalovirus Infection After R+HID-HSCT

Who this might be right for
The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
Institute of Hematology & Blood Diseases Hospital, China 21
Next Page